What is Alto Neuroscience's compensation and benefits?

Alto Neuroscience (ANRO) reported compensation and benefits of $2M in Q1 2026.

How has Alto Neuroscience's compensation and benefits changed year-over-year?

Alto Neuroscience's compensation and benefits decreased by 1.8% year-over-year, from $2.04M to $2M.

What is the long-term trend for Alto Neuroscience's compensation and benefits?

Over 2 years (2023 to 2025), Alto Neuroscience's compensation and benefits has grown at a 206.6% compound annual growth rate (CAGR), from $518K to $4.87M.

Alto Neuroscience ANRO Compensation and benefits

Compensation and benefits at other companies

StrykerSYK

$885M-3.7%

Arrowhead ResearchARWR

——

Supernus PharmaceuticalsSUPN

——

IAR

Integra LifeSciencesIART

——

Tempus AI, Inc.TEM

——

Lantheus HoldingsLNTH

——

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's compensation and benefits?: Alto Neuroscience (ANRO) reported compensation and benefits of $2M in Q1 2026.
How has Alto Neuroscience's compensation and benefits changed year-over-year?: Alto Neuroscience's compensation and benefits decreased by 1.8% year-over-year, from $2.04M to $2M.
What is the long-term trend for Alto Neuroscience's compensation and benefits?: Over 2 years (2023 to 2025), Alto Neuroscience's compensation and benefits has grown at a 206.6% compound annual growth rate (CAGR), from $518K to $4.87M.